Chemical Synthesis, Purification and Folding of the Human Monocyte Chemotactic Proteins MCP-2 and MCP-3 into Biologically Active Chemokines
Overview
Affiliations
Monocyte chemotactic proteins 2 and 3 (MCP-2 and MCP-3) are chemokines structurally and functionally related to MCP-1. In contrast to MCP-1, they are produced in low amounts by stimulated leukocytes or tumour cells. As an alternative method to generate sufficient protein for in vitro and in vivo characterization of MCP-2 and MCP-3, we have synthesized both 76-residue chemokines using Fmoc chemistry. After automated solid phase peptide synthesis at a 0.05 to 0.25 mmol scale, and purification to homogeneity by C-8 RP-HPLC, correct disulfide bridges were formed in a mixture of oxidized and reduced glutathione. The synthesis was biochemically controlled by peptide sequencing of intermediate products and proteolytic fragments of the 76-residue chemokines and by mass analysis. Purified synthetic MCP-2 and MCP-3 coeluted and comigrated with their natural counterparts on analytical reverse phase columns and SDS-PAGE, respectively. Purified and folded MCP-2 and MCP-3 were chemotactic for monocytes at 7.5 ng/ml and 5 ng/ml, respectively. These minimal effective concentrations are comparable to those of the natural chemokines. Synthetic MCPs did not induce neutrophil chemotaxis. Automated Fmoc peptide synthesis is thus a useful method, allowing fast production of chemokines and analogues thereof.
Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis.
Forster-Ruhrmann U, Szczepek A, Pierchalla G, Fluhr J, Artuc M, Zuberbier T J Pers Med. 2022; 12(4).
PMID: 35455762 PMC: 9025930. DOI: 10.3390/jpm12040646.
Vandooren J, Born B, Solomonov I, Zajac E, Saldova R, Senske M Biochem J. 2014; 465(2):259-70.
PMID: 25360794 PMC: 4399976. DOI: 10.1042/BJ20140418.
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D J Clin Invest. 1999; 104(4):R1-5.
PMID: 10449444 PMC: 481049. DOI: 10.1172/JCI7318.
Schols D, Proost P, Van Damme J, De Clercq E J Virol. 1997; 71(10):7300-4.
PMID: 9311806 PMC: 192073. DOI: 10.1128/JVI.71.10.7300-7304.1997.